Chris Katje January 23, 2026 at 9:31 PM Berkshire Hathaway Inc (NYSE:BRK)(NYSE:BRK) shares underperformed the S&P 500 in 2025, marking a rare miss in
Latest News
Palantir Billionaire Peter Thiel Sells Tesla and Buys This Consumer Electronics Stock Instead
Peter Thiel significantly reduced exposure to Tesla stock and swapped his gains for Apple. While Peter Thiel‘s roots are in entrepreneurship, the billionaire has
Palantir Billionaire Peter Thiel Sells Tesla and Buys This Consumer Electronics Stock Instead
According to recent filings, the Thiel Macro fund sold 76% of its position in Tesla ( TSLA 0.04%) and redeployed capital into another trillion-dollar
Dow Jones futures: Tesla, Microsoft, Meta, Apple lead earnings wave; what to do now
Tesla, Microsoft, Meta and Apple lead an earnings wave after the stock market weathered whipsaw action from President Trump’s moves …
In the case of the Federal Reserve, Supreme Court appears to carve out a murky exception
WASHINGTON (AP) — The Supreme Court for the past year has repeatedly allowed President Donald Trump to fire heads of independent agencies, but it
Tesla Inc Put Options Still Look Attractive to Short-Sellers Before Earnings Next Week
Tesla Inc. (TSLA) out-of-the-money puts have attractive premiums over the next month. I discussed this in a Barchart article three weeks ago, and short-sellers
Bitcoin ETFs Bleed $1.62B in Four Days — Are Hedge Funds Dumping BTC?
Bitcoin spot exchange-traded funds have experienced steep outflows over four trading days, losing a combined total of $1.62 billion. The exit has raised a
Stock market today: Dow, S&P 500 cap volatile week with back-to-back weekly losses
A preliminary reading on S&P Global’s US Manufacturing PMI showed the activity-tracking index hitting 51.9 in January. That was slightly below the 52 expected
How major US stock indexes fared Friday, 1/23/2026
The U.S. stock market finished its zigzag week full of tariff threats and cancellations with a quiet and tentative close. The S&P 500 closed
Stock Market Today, Jan. 23: ImmunityBio Falls After Gaining Over 200% in a Month
Today, Jan. 23, 2026, profit taking and fresh glioblastoma survival data weighed on a soaring biotech stock. ImmunityBio Today’s Change (-12.13%) $-0.89 Current Price